HQS Quantum Simulations
Rintheimer Straße 23, Karlsruhe, Baden-Wurttemberg, 76131, Germany
Overview
HQS Quantum Simulations, founded in 2017 as a spin-off of the Karlsruhe Institute of Technology, develops efficient quantum algorithms and software for simulating quantum systems on classical and quantum hardware. Its flagship offerings include the HQS Quantum Assisted Design cloud platform and the open-source Active Space Finder library, aimed at enabling material, chemical and pharmaceutical research workflows. The company supplies software for the Q-Exa consortium and is involved in providing software for the first quantum computer manufactured in Germany to be installed at the Leibniz Supercomputing Centre. With more than 30 scientists on staff, HQS positions itself as a leading European quantum-simulation startup. Following a Series A, the company raised more than €12 million alongside additional research funding and plans to use the capital to enhance its cloud platform, expand its open-source library, grow the team and strengthen its customer base. HQS is developing software optimized for near-term quantum computers to allow research groups and companies without hardware access to run the same simulations. HQS Quantum Simulations provides software that enables chemical and material science companies to run quantum chemical and advanced material simulations on near-term NISQ processors. The company's core product predicts material and chemical properties using quantum computers to accelerate development cycles in the chemistry and pharma industries. HQS was founded in 2017 as a spin-off from the Karlsruhe Institute of Technology and is based in Karlsruhe, Germany. It has established collaborations with BASF, Bosch and Merck. The company was initially backed by angel investors Friedrich Hoepfner and Manfred Ziegler. HQS intends to use the €2.3M seed funding to strengthen its quantum simulation team.
- Total raised
- $16M
- Funding rounds
- 2
- Latest round
- Series A
- Latest activity
- Jan 2022
Industries
- Chemical
- Pharmaceutical
Recent funding
Series A
Jan 2022
$14M
Seed
Oct 2019
$3M